Science Explorer Back to mapMap
Discussion
Company · Bothell · United States

Seagen (United States)

In research, Seagen (United States) stands highest in Health Sciences (#1,849 of 16,688 worldwide), Medicine (#2,193 of 14,558 worldwide) and Life Sciences (#2,838 of 11,023 worldwide), over all time. Relative to its size it is most specialised in Oncology (Oncology is 21.0× its share of world research).

World rank, 2022-now
#21,633
of 22,385 · #6,463 all time
Rank in United States
#3,205
of 3,332
Research works
613
▼ 34% vs 2018-21
Citations
56k
90.7 per fractional work
Top-10% rate
14.0%
all institutions 10.0%
vs its own fields
1.00×
1.00× is exactly expected
Open access
30%
world 40%
International
14%
world 18%

What is Seagen (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #1,849 of 16,688 24.3%380
MedicineField #2,193 of 14,558 24.0%371
Life SciencesDomain #2,838 of 11,023 17.3%181
Biochemistry, Genetics and Molecular BiologyField #1,772 of 5,801 18.1%130
OncologySubfield #499 of 1,474 24.7%129

Each strip is that field's whole ranked pool, with the notch where Seagen (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Seagen (United States) work in?

In 2022-now, 69% of research at Seagen (United States) is in Health Sciences, 19% in Life Sciences. Its largest fields are Medicine (67%), Biochemistry, Genetics and Molecular Biology (12%), Immunology and Microbiology (6%). It does 2.7× the world's share of Health Sciences.

Health Sciences: 59 fractional works · 68.6% of its workMedicine: 58 fractional works · 67.3% of its workOncology: 20 fractional works · 23.6% of its workPulmonary and Respiratory Medicine: 10 fractional works · 11.1% of its workRadiology, Nuclear Medicine and Imaging: 6 fractional works · 6.9% of its workSurgery: 6 fractional works · 6.8% of its workPathology and Forensic Medicine: 5 fractional works · 5.4% of its workEpidemiology: 2 fractional works · 1.9% of its workImmunology and Allergy: 1 fractional works · 1.4% of its workGenetics: 1 fractional works · 1.2% of its workDermatology: 1 fractional works · 1.1% of its workObstetrics and Gynecology: 1 fractional works · 0.9% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.8% of its workHematology: 1 fractional works · 0.8% of its workInfectious Diseases: 1 fractional works · 0.7% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 0.6% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 0.6% of its workRheumatology: 0 fractional works · 0.5% of its workNeurology: 0 fractional works · 0.5% of its workPsychiatry and Mental health: 0 fractional works · 0.4% of its workOtorhinolaryngology: 0 fractional works · 0.4% of its workPhysiology: 0 fractional works · 0.3% of its workPharmacology: 0 fractional works · 0.3% of its workReproductive Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 1.1% of its workHealth Professions: 0 fractional works · 0.5% of its workVeterinary: 0 fractional works · 0.4% of its workSmall Animals: 0 fractional works · 0.4% of its workNursing: 0 fractional works · 0.3% of its workNutrition and Dietetics: 0 fractional works · 0.3% of its workDentistry: 0 fractional works · 0.1% of its workLife Sciences: 16 fractional works · 19.0% of its workBiochemistry, Genetics and Molecular Biology: 10 fractional works · 11.5% of its workMolecular Biology: 7 fractional works · 7.6% of its workGenetics: 1 fractional works · 1.3% of its workCancer Research: 1 fractional works · 1.2% of its workBiotechnology: 1 fractional works · 0.9% of its workBiophysics: 0 fractional works · 0.3% of its workCell Biology: 0 fractional works · 0.3% of its workImmunology and Microbiology: 5 fractional works · 6.1% of its workImmunology: 5 fractional works · 6.0% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 0.7% of its workPharmacology: 0 fractional works · 0.5% of its workPharmaceutical Science: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.5% of its workAgricultural and Biological Sciences: 0 fractional works · 0.2% of its workPhysical Sciences: 7 fractional works · 8.5% of its workEngineering: 3 fractional works · 3.0% of its workElectrical and Electronic Engineering: 1 fractional works · 1.4% of its workBiomedical Engineering: 1 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workComputer Science: 1 fractional works · 1.7% of its workComputer Networks and Communications: 0 fractional works · 0.6% of its workComputational Theory and Mathematics: 0 fractional works · 0.5% of its workArtificial Intelligence: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemistry: 1 fractional works · 1.6% of its workOrganic Chemistry: 1 fractional works · 1.6% of its workMathematics: 1 fractional works · 1.1% of its workStatistics and Probability: 1 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 1 fractional works · 0.8% of its workBiomaterials: 0 fractional works · 0.4% of its workMaterials Chemistry: 0 fractional works · 0.4% of its workEnvironmental Science: 0 fractional works · 0.4% of its workEcology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 3 fractional works · 3.9% of its workEconomics, Econometrics and Finance: 3 fractional works · 3.1% of its workEconomics and Econometrics: 3 fractional works · 3.1% of its workSocial Sciences: 0 fractional works · 0.4% of its workDecision Sciences: 0 fractional works · 0.2% of its workManagement Science and Operations Research: 0 fractional works · 0.2% of its workPsychology: 0 fractional works · 0.2% of its workALL ITS WORKSeagen (UnitedStates)86fractional works, 2022-now
Life Sciences19%Physical Sciences9%Health Sciences69%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 20 fields, with their numbers
    1. Medicine5867.3%
    2. Health Professions00.5%
    3. Veterinary00.4%
    4. Nursing00.3%
    5. Dentistry00.1%
    1. Biochemistry, Genetics and Molecular Biology1011.5%
    2. Immunology and Microbiology56.1%
    3. Pharmacology, Toxicology and Pharmaceutics10.7%
    4. Neuroscience00.5%
    5. Agricultural and Biological Sciences00.2%
    1. Engineering33.0%
    2. Computer Science11.7%
    3. Chemistry11.6%
    4. Mathematics11.1%
    5. Materials Science10.8%
    6. Environmental Science00.4%
    1. Economics, Econometrics and Finance33.1%
    2. Social Sciences00.4%
    3. Decision Sciences00.2%
    4. Psychology00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Seagen (United States) specialise in?

Where its research is concentrated relative to its size: Oncology takes 21.0× the share of its output that it takes of world research.

  1. OncologySubfield · 20.4 works21×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.05× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.16× its world share, 10 worksBiochemistry, Geneti…Immunology and Microbiology: 6.02× its world share, 5 worksImmunology and Micro…Neuroscience: 0.29× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.93× its world share, 1 worksPharmacology, Toxico…Chemistry: 1.04× its world share, 1 worksChemistryComputer Science: 0.22× its world share, 2 worksComputer ScienceEngineering: 0.20× its world share, 3 worksEngineeringEnvironmental Science: 0.07× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.22× its world share, 1 worksMaterials ScienceMathematics: 0.91× its world share, 1 worksMathematicsDentistry: 0.11× its world share, 0 worksDentistryHealth Professions: 0.19× its world share, 0 worksHealth ProfessionsMedicine: 3.50× its world share, 58 worksMedicineNursing: 0.66× its world share, 0 worksNursingVeterinary: 2.99× its world share, 0 worksVeterinaryDecision Sciences: 0.25× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.43× its world share, 3 worksEconomics, Econometr…Psychology: 0.07× its world share, 0 worksPsychologySocial Sciences: 0.04× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.0×. Every wedge is a field page.

All 20 fields, with their numbers
  1. Immunology and Microbiology6.02×5 works
  2. Medicine3.50×58 works
  3. Veterinary2.99×0 works
  4. Biochemistry, Genetics and Molecular Biology2.16×10 works
  5. Pharmacology, Toxicology and Pharmaceutics1.93×1 works
  6. Economics, Econometrics and Finance1.43×3 works
  7. Chemistry1.04×1 works
  8. Mathematics0.91×1 works
  9. Nursing0.66×0 works
  10. Neuroscience0.29×0 works
  11. Decision Sciences0.25×0 works
  12. Computer Science0.22×2 works
  13. Materials Science0.22×1 works
  14. Engineering0.20×3 works
  15. Health Professions0.19×0 works
  16. Dentistry0.11×0 works
  17. Environmental Science0.07×0 works
  18. Psychology0.07×0 works
  19. Agricultural and Biological Sciences0.05×0 works
  20. Social Sciences0.04×0 works

Who are the top researchers at Seagen (United States)?

Ranked on the quality score, Peter D. Senter, Shyra J. Gardai and Che‐Leung Law lead among researchers whose main affiliation is Seagen (United States).

  1. 1 Peter D. Senter United States · #71,519 worldwide 18k citations · 236 works
  2. 2 Shyra J. Gardai United States · #102,981 worldwide 5.7k citations · 199 works
  3. 3 Che‐Leung Law United States · #114,295 worldwide 7.1k citations · 274 works
  4. 4 Paul J. Carter United States · #118,206 worldwide 6.8k citations · 99 works
  5. 5 Iqbal S. Grewal United States · #125,534 worldwide 13k citations · 191 works
  6. 6 Martha E. Anderson United States · #150,143 worldwide 3.2k citations · 97 works
  7. 7 Alan F. Wahl United States · #152,493 worldwide 8.6k citations · 85 works
  8. 8 Mechthild Jonas United States · #157,416 worldwide 5k citations · 109 works
  9. 9 Nicole M. Okeley United States · #222,906 worldwide 4k citations · 128 works
  10. 10 Ivan J. Stone United States · #239,952 worldwide 2.5k citations · 121 works
All ranked researchers at Seagen (United States)

What are the most cited papers from Seagen (United States)?

The most cited paper from Seagen (United States) is "CONFIDENCE LIMITS ON PHYLOGENIES: AN APPROACH USING THE BOOTSTRAP" (Joseph Felsenstein, 1985), with 41,763 citations. Next come "A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae" (4,754) and "The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3" (3,417).

Most cited papers
#PaperReleasedCitations
1 CONFIDENCE LIMITS ON PHYLOGENIES: AN APPROACH USING THE BOOTSTRAP Joseph Felsenstein · Evolution Open access Jul 1985 41,763
2 A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae Peter H Uetz, Loïc Giot, Gerard Cagney et al. · Nature Feb 2000 4,754
3 The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 Craig L. Bennett, Jacinda R. Christie, Fred Ramsdell et al. · Nature Genetics 2001 3,417
4 Cases in which Parsimony or Compatibility Methods will be Positively Misleading Joe Felsenstein · Systematic Biology Dec 1978 2,953
5 VEGF Inhibition and Renal Thrombotic Microangiopathy Vera Eremina, J. Ashley Jefferson, Jolanta Kowalewska et al. · New England Journal of Medicine Open access 12 Mar 2008 1,514
All 60 most cited papers, with filters and sorting

Which keywords describe research at Seagen (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Breast Cancer, Immunotherapy, Trastuzumab, Monoclonal Antibody, Metastatic, Lymphoma and EGFR.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy17▲ 28×15 topics
  2. Breast Cancer10▲ 47×3 topics
  3. Immunotherapy10▲ 16×13 topics
  4. Monoclonal Antibody8▲ 173×2 topics
  5. Trastuzumab8▲ 191×2 topics
  6. Lymphoma8▲ 58×3 topics
  7. Metastatic8▲ 143×2 topics
  8. EGFR8▲ 287×1 topic
  9. HER28▲ 287×1 topic
  10. Monoclonal Antibodies6▲ 83×3 topics
  11. Glycosylation6▲ 61×3 topics
  12. Targeted Therapy6▲ 30×5 topics
  13. PET Imaging6▲ 38×5 topics
  14. Rituximab5▲ 43×2 topics
  15. Therapeutic Antibodies5▲ 90×2 topics
  16. Antibody Engineering5▲ 107×1 topic
  17. Fc Receptors5▲ 107×1 topic
  18. Molecular Characterization5▲ 32×4 topics
  19. Clinical Trials5▲ 8.2×7 topics
  20. Gene Expression Profiling5▲ 70×2 topics
  21. Molecular Profiling5▲ 58×2 topics
  22. Cancer Immunotherapy5▲ 35×3 topics
  23. Neoadjuvant Therapy4▲ 22×4 topics
  24. Classification4▲ 11×1 topic
  25. Genetic Pathogenesis4▲ 97×1 topic
  26. Tumor Regression4▲ 43×2 topics
  27. Genomic Profiling4▲ 45×2 topics
  28. Treatment Guidelines4▲ 21×2 topics
  29. Tumor Microenvironment4▲ 10×4 topics
  30. ALK Inhibitors4▲ 74×1 topic
  31. EGFR Mutations4▲ 74×1 topic
  32. Leukemia4▲ 51×2 topics
  33. CAR T Cells4▲ 55×1 topic
  34. Chimeric Antigen Receptor4▲ 55×1 topic
  35. Prognostic Factors4▲ 9.2×10 topics
  36. Bladder Cancer3▲ 101×1 topic
  37. Urothelial Carcinoma3▲ 88×1 topic
  38. Metastatic Breast Cancer3▲ 65×2 topics
  39. Immune Checkpoint Blockade3▲ 33×1 topic
  40. PD-1 and PD-L13▲ 33×1 topic

Which research topics does Seagen (United States) publish most on?

By volume in 2022-now: HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Lymphoma Diagnosis and Treatment and Lung Cancer Treatments and Mutations.

  1. 1 HER2/EGFR in Cancer Research Oncology 8 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 5 works
  3. 3 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 4 works
  4. 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
  5. 5 CAR-T cell therapy research Oncology 4 works
  6. 6 Bladder and Urothelial Cancer Treatments Surgery 3 works
  7. 7 Cancer Immunotherapy and Biomarkers Oncology 3 works
  8. 8 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
  9. 9 Economic and Financial Impacts of Cancer Economics and Econometrics 2 works
  10. 10 Colorectal Cancer Treatments and Studies Oncology 2 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.9%not open70.1%

World: 40% of research is openly available.

with international co-authors13.6%domestic only86.4%

World: 18% is written across borders.

How has Seagen (United States)'s research output changed?

Output in 2022-2025 was 34% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Seagen (United States) as a percentage of every work published that year, 0.00027% in 2024.

still counting0.00050%0.0010%0.0015%Seagen (United States)0.000056% in 202519801990200020102020

Fractional works of Seagen (United States) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

20%40%Seagen (United States)19.1% in 2023all institutions10.0% in 202320102020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 39.4% in 2014.

Other research institutions in Bothell

All research institutions in Bothell

Share Seagen (United States)'s ranking

Seagen (United States) on Science Explorer

A card with Seagen (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Seagen (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.